← FDA Drug Approvals (Drugs@FDA)

DOXYCYCLINE HYCLATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AVET LIFESCIENCES · Approved 2026-02-19

Drug application

FDA Application #

ANDA203276

Application type

Abbreviated New Drug Application (Generic)

Brand name

DOXYCYCLINE HYCLATE

Generic name

Doxycycline Hyclate

Active ingredients

DOXYCYCLINE HYCLATE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

AVET LIFESCIENCES

First approval

2026-02-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown